.svg){kind=small}
Dec-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In California, Clsics has shown notable performance across several categories, particularly in Concentrates and Vapor Pens. The brand has consistently improved its ranking in the Concentrates category, moving from 27th in September 2025 to 18th by December 2025, with a significant increase in sales, indicating a strengthening market presence. In the Vapor Pens category, Clsics maintained a steady position, fluctuating slightly but ending the year strong at 13th place. This stability suggests a loyal customer base and effective product offerings in this category. However, it's worth noting that Clsics was not in the top 30 for some categories in other states, which could indicate room for improvement or a need for strategic adjustments in those markets.
In the Edible category, Clsics experienced some fluctuations in California, starting at 15th in September, peaking at 13th in October, and then dropping back to 18th by December. This movement could reflect changing consumer preferences or competitive pressures within the market. The Pre-Roll category saw Clsics holding a consistent position, ending the year at 18th, which suggests a steady demand for their products in this segment. Despite the challenges in maintaining high rankings across all categories, the overall upward trend in sales, particularly in Concentrates, indicates that Clsics is gaining traction and could potentially leverage this momentum to improve its standings further in the coming months.
Competitive Landscape
In the competitive landscape of the California Vapor Pens category, Clsics has experienced notable fluctuations in its market position from September to December 2025. Initially ranked 15th in September and October, Clsics saw a dip to 16th in November before climbing to 13th in December. This upward movement in December suggests a positive response to market strategies, despite facing stiff competition. For instance, West Coast Cure consistently improved its rank from 14th to 11th over the same period, indicating robust sales growth. Meanwhile, Cold Fire, which started at 6th, experienced a decline to 12th, potentially opening opportunities for Clsics to capture more market share. Additionally, Dabwoods Premium Cannabis saw a decline from 13th to 15th, which could further benefit Clsics if it continues to leverage its strategic initiatives effectively. Overall, Clsics' ability to rebound in December amidst a competitive environment highlights its potential for sustained growth in the California market.
Notable Products
In December 2025, the top-performing product from Clsics was the Blackberry Fire Live Rosin Gummies 10-Pack (100mg), which climbed to the number one rank with sales reaching 4077 units. The Berry Prism Rosin Gummies 10-Pack (100mg) saw a significant rise, moving up to second place from fourth in November. The Blue Crack Live Rosin Disposable (1g) maintained a steady presence, holding the third position for the month. Meanwhile, the CBD/CBN/THC 1:1:1 Blueberry Milk Live Rosin Gummies 10-Pack (100mg CBD, 100mg CBN, 100mg THC) dropped to fourth place from its first-place ranking in October and November. Lastly, the Watermelon Haze Live Rosin Gummies 10-Pack (100mg) entered the rankings in December, securing the fifth spot.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
